European Union Should Actively Stimulate and Harmonise Neonatal Screening Initiatives
- PMID: 33072953
- PMCID: PMC7510224
- DOI: 10.3390/ijns4040032
European Union Should Actively Stimulate and Harmonise Neonatal Screening Initiatives
Abstract
Neonatal screening programmes have been introduced in almost all European countries. In practice there are large differences, especially in the panel of conditions that are screened for, often without clear reasons. Policy making on a European level is lacking in contrast to the situation in the USA. Professionals have the knowledge to expand the panels but are dependent on policy-makers for the necessary funds. This paper is a call on the EU Commission to take up a role in providing equal access to neonatal screening for all children within the EU.
Keywords: (recommended) screening panel; harmonisation; patient advocacy; policy making.
© 2018 by the author.
Conflict of interest statement
Conflicts of InterestThe author declares no conflict of interest.
References
-
- Guthrie R., Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338–343. - PubMed
-
- Dussault J.H., Laberge C. Thyroxine (T4) determination by radioimmunological method in dried blood eluate: New diagnostic method of neonatal hypothyroidism? Union Med. Can. 1973;102:2062–2064. - PubMed
-
- Chace D.H., Millington D.S., Terada N., Kahler S.G., Roe C.R., Hofman L.H. Rapid diagnosis of phenylketonuria by quantitative analysis of phenylalanine and tyrosine in neonatal blood spots using tandem mass spectrometry. Clin. Chem. 1993;39:66–71. - PubMed
-
- Wilson J.M., Jungner Y.G. Principles and practice of mass screening for disease. Bull. WHO. 1968;65:281–393. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
